February 16, 2019

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
16
Feb
Recent Federal Developments February 15, 2019 EPA /FDA / TSCA / FIFRA /TRI Bergeson & Campbell, P.C.
15
Feb
NC CBD Companies Take Notice: NC Dept. of Agriculture Issues CBD Advisory Ward and Smith, P.A.
15
Feb
McDermottPlus Check-Up: February 15, 2019 McDermott Will & Emery
15
Feb
FDA Publishes Findings from Investigation of Romaine Lettuce E. coli Outbreak Keller and Heckman LLP
14
Feb
Regulatory Developments EC Begins Public Consultation on Evaluation of FCMs Bergeson & Campbell, P.C.
14
Feb
FDA Takes Action on Dietary Supplements Claiming to Treat Alzheimer’s Disease and Other Serious Conditions Keller and Heckman LLP
14
Feb
Remote Prescribing Trends in Telehealth Epstein Becker & Green, P.C.
14
Feb
HIMMS19 Conference – Blockchain Symposium Recap Sheppard, Mullin, Richter & Hampton LLP
13
Feb
CBD “Edibles” Face Opposition from States, FDA Epstein Becker & Green, P.C.
13
Feb
JRC Publishes Overview of Concepts and Terms Used in the EC’s Definition of Nanomaterial Bergeson & Campbell, P.C.
13
Feb
DOJ Expands New Enforcement Tactic – Obtains TRO to Prevent Pharmacy From Dispensing Opioids McDermott Will & Emery
13
Feb
New York Judge Lifts 2-Year Stay on KIND “All Natural” Suit Keller and Heckman LLP
12
Feb
New York City Bans CBD from Bars and Restaurants Wilson Elser Moskowitz Edelman & Dicker LLP
12
Feb
Update on Pending Legislation: Three New Bills Have the Potential to Affect Generic Pharmaceutical Companies Polsinelli PC
12
Feb
FDA Adds Three New Substances to its Inventory of Effective FCS Notifications Keller and Heckman LLP
12
Feb
FDA to Strengthen Dietary Supplements Regulation Keller and Heckman LLP
11
Feb
In Surprising Ruling, McDonald’s Loses BIG MAC Trademark Registration In The EU Barnes & Thornburg LLP
11
Feb
HHS Proposes Rule to Eliminate Safe Harbor for PBM Drug Rebates Sheppard, Mullin, Richter & Hampton LLP
11
Feb
E-cigarette Companies Raising Nicotine Levels to Compete with Juul Stark & Stark
11
Feb
45 States Now Have Biosimilar Substitution Laws Mintz

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS

Upcoming Legal Education Events

Thursday, February 21, 2019
Tuesday, February 26, 2019
Wednesday, February 27, 2019
Wednesday, February 27, 2019
Wednesday, February 27, 2019
Wednesday, February 27, 2019
Thursday, February 28, 2019
Wednesday, October 23, 2019